Corporate News     01-Jul-26 Lupin receives EMA approval for Pediatric Indication of NaMuscla Lupin today announced that the European Medicines Agency (EMA) has approved a change to the terms of marketing authorization for NaMuscla, supported by the Pediatric Investigation Plan (PIP). The approval includes two new dosage strengths, 62 mg and 83 mg capsules, in addition to the existing 167 mg, and the revised indications that cover symptomatic treatment of myotonia in children (6¨C11 years, weighing at least 20 kg), adolescents (12¨C17 years), and adults (¡Ý18 years) with non-dystrophic myotonic disorder. Previous News   Lupin Ltd slips for fifth straight session  ( Hot Pursuit - 11-Aug-26   13:35 )   Lupin receives USFDA approval for Sodium Zirconium Cyclosilicate for Oral Suspension  ( Corporate News - 10-Aug-26   18:39 )   Lupin  ( Results - Analysis 07-Aug-26   10:55 )   Lupin consolidated net profit rises 16.08% in the June 2026 quarter  ( Results - Announcements 07-Aug-26   07:34 )   Lupin receives USFDA approval for Diazepam Injection USP  ( Corporate News - 31-Jul-26   18:40 )   Lupin launches Sugammadex Injection in U.S. market  ( Corporate News - 31-Jul-26   12:27 )   Lupin to table results  ( Corporate News - 23-Jul-26   10:01 )   Lupin grants exclusive rights to Kaveri Therapeutics Inc. for advancing two oncology programs  ( Corporate News - 21-Jul-26   09:08 )   Lupin to convene AGM  ( Corporate News - 09-Jul-26   10:40 )   Lupin allots 2,358 equity shares under ESOP  ( Corporate News - 08-Jul-26   17:45 )   Lupin fixes record date for final dividend  ( Market Beat - Reports 08-Jul-26   17:39 )	Other Stories   Affle 3i allots 34,964 equity shares on conversion of warrants   14-Aug-26   17:40   Greaves Cotton acquires balance 20% stake in Excel Controlinkage   14-Aug-26   17:24   Board of Ashok Leyland approves investment in subsidiaries   14-Aug-26   17:12   Board of Info Edge (India) approves investment of Rs 90 cr in Startup Investments (Holding)   14-Aug-26   17:00   Board of Info Edge (India) approves investment of Rs 8.90 cr in Udyogtech Ventures   14-Aug-26   16:54   Adani Energy Solutions acquires Vizag Power Transmission   14-Aug-26   16:34   Ideaforge Technology allots 14,135 equity shares under ESOS   14-Aug-26   16:30   Wipro allots 1.41 lakh equity shares under ESOP   14-Aug-26   16:02   Board of Bhatia Communications & Retail (I) recommends interim dividend   14-Aug-26   15:59   Ekansh Concepts to conduct AGM   14-Aug-26   15:58
Back Top